Abstract. In this retrospective longitudinal study, we focused on the clinical characteristics of Japanese individuals with recent onset impaired glucose tolerance (IGT) who have been followed up for insulin secretory function and 75-gram oral glucose tolerance test (OGTT) for more than 3 years annually before they progressed from normal glucose tolerance (NGT) to IGT. Subjects whose body weight did not show significant change for the period were selected and labeled as either NGT (no change in OGTT over 3 years) or IGT (progressors from NGT to IGT) groups (n = 24, each). We compared the basal biochemical data and response of plasma glucose and serum insulin after OGTT of the two groups. In the IGT progressors, significant increase of plasma glucose at 30 to 120 minutes during OGTT and significant decrease of HDL-cholesterol were observed since 3 years before onset of IGT. In addition to increase of serum glucose and decrease of HDL-cholesterol, serum insulin at 120 minutes during OGTT were significantly and remarkably high at onset and 3 years before onset of IGT. Plasma glucose at 30-120 minutes and serum insulin level at 120 minutes after glucose load are potentially significant predictors of progression from NGT to IGT even in subjects who do not show increase of body weight. DISRUPTION of the normal kinetics of insulin secretion in the form of impaired early insulin secretion is seen in the appearance of type 2 diabetes mellitus [1, 2] . In addition to the impaired early insulin release, apparent increase of body weight is observed in individuals who show a change in glucose tolerance from normal (NGT) to impaired (IGT) [2, 3] . The increase of body weight leads to IGT and then to diabetic [2] . The increase of body weight usually leads to enhancement of insulin resistance. The presence of insulin secretory dysfunction and secondary insulin impairment accompanied by increase of body weight exacerbate glucose intolerance. However, a proportion of subjects with NGT progress to IGT without increase in body weight. To identify the factors associated with progression from NGT to IGT without associated increase in body weight which may cover up the other factors, 24 Japanese subjects who showed progression from NGT to IGT were recruited in the present study from among 302 NGT subjects who had undergone 75-gram oral glucose tolerance test (OGTT) annually for more than three years in our hospital. Only subjects with stable body weight were enrolled in this study to exclude the effect of this change on the NGT-IGT progression. We examined the changes in biochemical tests and the responses of plasma glucose and insulin to oral glucose load at 3 years before and at onset of IGT and compared the results with those of subjects who showed persistently NGT in a longitudinal retrospective study.
DISRUPTION of the normal kinetics of insulin secretion in the form of impaired early insulin secretion is seen in the appearance of type 2 diabetes mellitus [1, 2] . In addition to the impaired early insulin release, apparent increase of body weight is observed in individuals who show a change in glucose tolerance from normal (NGT) to impaired (IGT) [2, 3] . The increase of body weight leads to IGT and then to diabetic [2] .
The increase of body weight usually leads to enhancement of insulin resistance. The presence of insulin secretory dysfunction and secondary insulin impairment accompanied by increase of body weight exacerbate glucose intolerance. However, a proportion of subjects with NGT progress to IGT without increase in body weight. To identify the factors associated with progression from NGT to IGT without associated increase in body weight which may cover up the other factors, 24 Japanese subjects who showed progression from NGT to IGT were recruited in the present study from among 302 NGT subjects who had undergone 75-gram oral glucose tolerance test (OGTT) annually for more than three years in our hospital. Only subjects with stable body weight were enrolled in this study to exclude the effect of this change on the NGT-IGT progression. We examined the changes in biochemical tests and the responses of plasma glucose and insulin to oral glucose load at 3 years before and at onset of IGT and compared the results with those of subjects who showed persistently NGT in a longitudinal retrospective study.
Subjects and Methods
A total of 302 subjects who had undergone 75 g OGTT annually for more than three years were screened retrospectively. Screening period was 10 years (1994) (1995) (1996) (1997) (1998) (1999) (2000) (2001) (2002) (2003) . Among them, 55 subjects who were newly diagnosed as IGT based on the criteria of the American Diabetes Associations (1997) after 3 years of NGT (labeled here as progressors) and 24 progressors whose body weight did not change during the same 3-year period, were enrolled in this study. We also enrolled 24 age-, sex-, and body mass index (BMI)-matched control subjects who had shown NGT over the period of 3 years (labeled as non-progressors) and stable body weight for the same period, from among 124 NGT individuals. The mean age, male/ female ratio and BMI of progressors and nonprogressors at onset of IGT were 59.3 ± 8.82 versus 59.3 ± 9.79 years, 20/4 versus 20/4, and 23.9 ± 1.76 versus 23.9 ± 1.86 kg/m 2 (±SD), respectively.
To eliminate the effect of increased body weight (powerful risk factor of IGT progression) on the progression of NGT to IGT, only subjects whose body weights had not changed over a period of 3 years (maximum change within 5%) were selected in both groups. We compared the results of biochemical blood tests and OGTT (glucose response and insulin) of both groups.
The insulinogenic index was used as an index of early-phase insulin secretion in OGTT [4, 5] . The insulinogenic index was defined as the ratio of the increment of insulin to that of plasma glucose 30 min after a glucose load. Insulin resistance was assessed by the R value of the homeostasis model (HOMA) of Matthews et al. [6] . All data were expressed as mean ± SD. Differences between groups were examined for statistical significance using the Student's ttest. Stepwise multivariate regression analysis was performed to elucidate the primary factors related to the progression from NGT to IGT in all subjects. A P value less than 0.05 denoted the presence of a statistically significant difference.
Results
There were no differences in family history and arterial blood pressure between progressors and nonprogressors. We compared the characteristics of progressors with those of non-progressors at onset of IGT. As shown in Table 1 , there were no differences in the mean concentrations of fasting serum insulin, total cholesterol, and triglyceride between the two groups. Fasting plasma glucose and glycohemoglobin were significantly higher and high density lipoprotein cholesterol was significantly lower in the progressors than non-progressors. HOMA-R, which represents insulin resistance, tended to be higher, albeit insignificantly, in the progressors than non-progressors. Next, we compared the characteristics of progressors with those of non-progressors at three years before onset of IGT. At that time, there were no differences in the mean values Data are mean ± SD. F-IRI: fasting serum immunoreactive insulin, HOMA-R: homeostasis model insulin resistance index P value* comparison of onset of IGT and 3 years before onset of IGT of progressors of BMI, fasting plasma glucose, total cholesterol, triglyceride, HOMA-R and fasting serum insulin between the two groups. However, glycohemoglobin was significantly higher and high density lipoprotein cholesterol were significantly lower in the progressors than non-progressors (Table 1) .
We also compared blood glucose and insulin responses during 75 g OGTT in progressors and nonprogressors at 3 years before and at development of IGT. At appearance of IGT, blood glucose concentrations at 30, 60, and 120 min after glucose load were significantly higher in progressors than non-progressors (Fig. 1a) . At 3 years earlier, these concentrations were also significantly higher in progressors than nonprogressors (Fig. 1c) . At baseline, the mean serum immunoreactive insulin (IRI) at 120 min was significantly higher and those at 30 and 60 min were almost similar in progressors than non-progressors (Fig. 1d) . At 3 years before the onset of IGT, serum IRI at 120 min was significantly higher while those at 30 and 60 min were similar in progressors than nonprogressors (Fig. 1b, d ). The insulinogenic index, which reflects early-phase insulin secretion, tended to be lower, albeit insignificantly, in the progressors than non-progressors.
To elucidate which parameter is a primary predictor of IGT progressor among the baseline and postloaded biochemical ones, we performed stepwise multivariate regression analysis. Under these analyses, plasma glucose at 30-120 min and serum IRI at 120 min were strongly significant parameters for progression from NGT to IGT, and HDL cholesterol was still a significant parameter ( Table 2 ). The insulinogenic index, fasting plasma glucose, or glycohemoglobin at 3 years earlier, did not show significant difference between NGT and IGT progressor ( Table 2) .
Next, we compared the results of biochemical blood tests and serum glucose and IRI concentrations in progressors after glucose load at development of IGT with those at 3 years earlier. During the same period, the body weight of these subjects did not change significantly. Fasting plasma glucose, IRI, lipid profile, and HOMA-R concentrations also did not change significantly (Table 1 ). The mean blood glucose concentration for the whole group at 120 min after glucose load at onset of IGT was significantly higher than that at 3 years earlier (Fig. 2) . Serum IRI concentrations at 0 to 60 min were similar and those at 120 min measured at onset of IGT tended to be higher, though not significantly so (p = 0.06), than at 3 years earlier. At 3 years before the onset of IGT, the IRI concentration at 60 min after glucose load was significantly higher than that at 120 min (p = 0.029). At onset of IGT, the IRI concentration at 120 min after glucose load tended to be higher than that at 60 min though not significantly so (p = 0.094).
Discussion
The American Diabetes Association (ADA) proposed new diagnostic criteria for diabetes and "pre-diabetes" states in 1997 [7] . Based on the criteria, "pre-diabetes" was divided into at least two categories: one is impaired fasting glucose (IFG) concentration in which fasting glucose is >110 but <126 mg/dl, while the other is impaired glucose tolerance (IGT) in which plasma glucose concentration at 120 min after 75 g oral glucose load is >140 but <200 mg/dl. Large-scale clinical studies have proved that IGT but not IFG is a major risk factor of coronary heart disease and mortality [8, 9] , indicating that only the mealtime glucose excursion is a significant risk factor for death, similar to type 2 diabetes. In this regard, IGT is a preventable condition. To prevent the progression from NGT to IGT, i.e., the development of IGT, it is clearly important to clarify the clinical factors associated with such progression. Increased body weight has been reported to be a major risk factor in this progression [2, 3] . To our knowledge, no studies have examined other factors, apart from body weight, that are potentially involved in the development of IGT. In the present study, which excluded subjects whose body weight changed during a 3-year period, significant increases in plasma glucose concentrations were noted at 30, 60 and 120 minutes after glucose load in the progressors even at 3 years before the onset of IGT. Significant preceding increases of plasma glucose after oral glucose load before onset of IGT have not been reported in longitudinal study on Japanese subjects previously. Remarkable increase of body weight might cover up these findings in previous studies. Moreover, a significant increase in serum insulin at 120 minutes after glucose load was also noted at 3 years before the onset. In the progressors, earlyphase insulin calculated as insulinogenic index was lower at 3 years before onset of IGT than at onset but not statistically significant under stepwise multivariate regression analysis. Abnormal b-cell function has been recognized as the major factor for the development of type 2 diabetes in Japanese population as well as other Asian people. The SWAN study assessed differences in insulin sensitivity and b-cell function between non-diabetic premenopausal and early perimenopausal non-Hispanic white women and African American, Chinese American, Japanese American, and non-Mexican-American Latino women [10] . In that study, Japanese Americans and Chinese Americans had lower HOMA% b cells than non-Hispanic whites, whereas African Americans had higher HOMA% b cells than non-Hispanic whites after correcting for confounders. In another study of 453 Japanese subjects with normal glucose tolerance, HOMA b-cells were lower in the over 30 years groups, while HOMA-IR increased with BMI [11] . Tanaka et al. [12] reported previously that early-insulin secretion is widely disrupted in those progressing from NGT to diabetes in Japanese population. Even in subjects with NGT, the rapid insulin secretion after 75 g oral glucose load was frequently delayed. In most cases with IGT and patients with early type 2 diabetes, rapid insulin secretion after 75 g oral glucose load was delayed and a compensatory hypersecretion was observed at 120 min after glucose load. Several other studies also reported the significance of lack of rapid insulin response after meal in the development of type 2 diabetes in Japanese individuals [13] [14] [15] [16] . Two reports on analyses of risk factors of progression from NGT to IGT in Japanese subjects using cross-sectional analysis have been published previously. Suzuki et al. [15] reported that reduced early-phase insulin secretion is the primary determinant of deterioration from NGT to IGT and isolated postchallenge hyperglycemia. In another cross-sectional analysis, the worsening from NGT to IGT in Japanese subjects was found to be associated with a decreased in early-phase insulin secretion in nonobese as well as obese subjects [13] . In the former report, serum insulin at fasting and 120 min after glucose load, and HOMA-IR were significantly high in IGT subjects, indicating that IGT subjects in that study had more serious reduction of insulin sensitivity (HOMA-IR Suzuki et al., compared with our study: 1.9 ± 0.2 vs. 1.4 ± 0.7). In the latter report, the mean IRI and HOMA-IR in both nonobese and obese subjects with IGT and non-progressors were not significantly different. In our study, IGT subjects developed IGT following a period in which glucose tolerance was normal. Their serum insulin at 120 min after glucose load was already high even at 3 years before the onset of IGT. The IGT subjects of the above two studies of cross-sectional analysis did not always have new onset IGT. Insulin resistance observed in these analyses may be the consequence of hyperglycemia after the onset of IGT.
In the present study, the peak of serum insulin response was observed at 60 min after oral glucose load in both non-progressors and IGT progressors. However, serum insulin at 60 min was significantly higher than that at 120 min after oral glucose load in nonprogressors and progressors at 3 years before onset of IGT. At onset of IGT, serum insulin concentrations at 60 and 120 min were not significantly different. These results are consistent with our previous report [12] . In comparison with IGT, isolated impaired fasting glucose did not exhibit a deficit in the early phase of insulin secretion [17, 18] .
We have previously reported that enhancement of early-phase insulin secretion by nateglinide, an insulin secretagogue, improved the glucose response after oral glucose load in early type 2 diabetes and IGT, although the subjects had moderate insulin resistance [19, 20] . The area under the curve indicating total insulin secretion did not change after administration of nateglinide. In that study, administration of nateglinide resulted in a significant decrease in serum insulin concentration at 120 min after glucose load. Increased serum insulin concentrations at 120 min after glucose load may be the consequence of disruption of early insulin release and secondary progression of mild insulin resistance that was not clearly detected by HOMA-IR values. Increased serum insulin concentration at 120 min may be more sensitive to insulin resistance than HOMA-IR. Soyama et al. have reported that HDL-cholesterol was correlated with HOMA-IR in 1,615 males who were admitted for a general health check-up. In their study HDL-cholesterol was lower in IGT and diabetic subjects than NGT but it was not statistically significant [21] . In our study, HDL-cholesterol was not strong but significant predictor of IGT progressor. Elimination of the factor in increase of body weight that has been reported as the strongest factor of the progression may enhance this parameter.
In conclusion, progressors in our study showed a mild decrease in insulinogenic index at 3 years before onset of IGT but not statistically significant. Instead, plasma glucose at 30-120 minutes and serum insulin concentration at 120 min after oral glucose load in the progressors were markedly increased at both onset and 3 years before onset of IGT in addition to mild but significant decrease of HDL-cholesterol. These results suggest that post-loaded glucose and insulin are the most sensitive predictors of progression from NGT to IGT even in subjects who do not show increase in body weight.
